Mary S. Brady MD FACS

  • Citations Per Year
Learn More
The tumor microenvironment after treatment with ipilimumab is not well described. Furthermore, the safety of surgery for patients being treated with ipilimumab for metastatic melanoma has not been well reported. This study analyzed the safety of surgery and the immune phenotype of tumors resected while on ipilimumab. From our prospective melanoma database,(More)
  • 1